Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
6.29
+0.02 (0.32%)
At close: Oct 3, 2024, 4:00 PM
6.28
-0.01 (-0.16%)
After-hours: Oct 3, 2024, 4:29 PM EDT
Journey Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Journey Medical stock have an average target of 9.50, with a low estimate of 8.50 and a high estimate of 11. The average target predicts an increase of 51.03% from the current stock price of 6.29.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DERM stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Lake Street | Lake Street | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +43.08% | Sep 6, 2024 |
Roth MKM | Roth MKM | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +74.88% | Jun 28, 2024 |
Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +35.14% | Feb 16, 2024 |
B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | -4.61% | Sep 7, 2023 |
B. Riley Securities | B. Riley Securities | Strong Buy Maintains $3 → $6 | Strong Buy | Maintains | $3 → $6 | -4.61% | Jul 12, 2023 |
Financial Forecast
Revenue This Year
58.24M
from 79.18M
Decreased by -26.44%
Revenue Next Year
87.70M
from 58.24M
Increased by 50.57%
EPS This Year
-1.00
from -0.21
EPS Next Year
-0.02
from -1.00
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 60.9M | 105.1M | 83.6M |
Avg | 58.2M | 87.7M | 81.2M |
Low | 55.6M | 62.6M | 78.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | -23.0% | 80.4% | -4.7% |
Avg | -26.4% | 50.6% | -7.4% |
Low | -29.8% | 7.5% | -11.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.89 | 0.56 | -0.44 |
Avg | -1.00 | -0.02 | -0.43 |
Low | -1.11 | -0.77 | -0.41 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.